Sweden's Meda snaps up Acton for $200M; GSK wins EU nod on Tafinlar; Lundbeck to appeal €94M antitrust fine;

@FiercePharma: Executives' TV confessions in China are A) suspect, and B) a disturbing trend. More | Follow @FiercePharma

@EricPFierce: A court-appointed receiver is selling off equipment, patents from failed biosimilars plant. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Vivus CEO resigns after one month on the job; forner J&J exec Seth H. Z. Fischer appointed. Release | Follow @CarlyHFierce

> Sweden's Meda has agreed to buy Acton Pharmaceuticals, a Massachusetts-based drugmaker that recently won approval for a new asthma treatment, in a $200 million deal. Report

> GlaxoSmithKline ($GSK) nabbed European approval for its new melanoma treatment Tafinlar. Release

> Denmark's Lundbeck said it would appeal a €94 million fine levied by EU antitrust authorities, citing important errors in the case. Report

> A bankruptcy judge appropved KV Pharmaceutical's reorganization plan; the drugmaker filed for bankruptcy protection last August. Report

> Novartis ($NVS) won European approval for its anti-inflammatory drug Ilaris for children with systemic juvenile idiopathic arthritis. Release

> Roche's ($RHHBY) new subcutaneous formula of its breast cancer drug Herceptin won approval in Europe. Report

> Chile's CFR Pharmaceuticals said it will decide within weeks whether to make a binding offer for South Africa's Adcock Ingram. Report

> Boehringer Ingelheim's inhaler device Respimat is as safe and effective for patients with chronic obstructive pulmonary disease (COPD) as its older HandiHaler, a study found. Report

Medical Device News

@FierceMedDev: Device companies seek legal advice as Chinese corruption crackdown carries on. Item | Follow @FierceMedDev

@MarkHFierce: Medtronic is already rolling out its hospital solutions/consulting business. Diversification proceeds in earnest. Release | Follow @MarkHFierce

@MichaelGFierce: ICYMI: European public health group gets behind tighter device controls. Item | Follow @MichaelGFierce

> Echo Therapeutics' largest shareholder urges rapid reforms. Article

> Taiwan to tackle device industry R&D, training incentives. Story

> Medtronic debuts health services arm. More

Biotech News

@FierceBiotech: ICYMI: Merck triggers patent war with Gilead over sofosbuvir rights. Story | Follow @FierceBiotech

@JohnCFierce: Schoenbaum's take on Amgen's demand for unblinded Kyprolis trial data: Poker move by Bradway to drop the price. | Follow @JohnCFierce

@RyanMFierce: ICYMI: Start-Up mag covered the trend of VC investments in clinical trials at major pharmas like Pfizer back in April. More | Follow @RyanMFierce

> U.K.'s Acacia banks $23.5M for PhIII drug to support cancer patients. Article

> PhII flop clouds future of Amgen, Cytokinetics heart failure drug. News

> Waksal brushes off jail time, plots biotech IPOs in a red-hot market. More

Pharma Manufacturing News

> Cubist recalls four lots of flagship antibiotic. More

> Quality issue keeps Apricus Biosciences from getting Swiss approval for Vitaros. Story

> Receiver selling off equipment, IP from failed biosimilars project. Article

> Hospira recalls product after hair found in one injector. News

> GSK gets interest from buyers for Romania plant. More

> India OKs Wockhardt plant banned by FDA. Report

Biotech Research News

@EmilyMFierce: Former cancer drug could treat diabetes, autoimmune diseases. More | Follow @EmilyMFierce

> Johnson & Johnson forges partnership to fight dengue fever. Article

> High blood pressure therapy speeds TB recovery. News

> Altered gene in mice extends lifespan by 20%. Report

> New opioid pain drug decreases tolerance, side effects. Story

> Worm genome reveals possible drug targets. Item

CRO News

> PPD snags Acurian for recruitment software. News

> CMO Lonza lopping off hundreds of jobs. More

> Duke's CRO nabs another trial deal. Story

> Psi expands in Italy amid global push. Report

> Report: Big CROs soared 10% last year. Article

Biotech IT News

> DNA software startup Desktop Genetics scores £375K in early funding. More

> Report: BGI readies for big genomics IPO. More

> Eagle Genomics captures £590,000 round to feed bioinformatics biz. Article

> AstraZeneca backs web portal for breast cancer docs. Story

> Quantia, provider of software to pharma, lands $10M B round. Item

> Eli Lilly, Humana partner on crunching diabetes data. Article

And Finally... The art and science of the power nap. Report

Suggested Articles

Novartis said it plans to use the complete response rate data for a U.S. filing in follicular lymphoma in 2021.

Sen. Elizabeth Warren asked the SEC to probe Kodak trades made before the Trump administration unveiled their drug supply deal—and $765M in funding.

Amarin's wild 2020 ride continues with plans to launch its cardiovascular med Vascepa in Europe without a bigger marketing partner.